跳至主要内容
临床试验/JPRN-jRCT1031200137
JPRN-jRCT1031200137已完成4 期

An Observational Study to Investigate the Relationship between Plasma Lyso-Gb1 Concentration and the Treatment Outcomes of Gaucher disease patients in Japan - Lyso-Gb1

Contact for Clinical Trial Information0 个研究点目标入组 20 人开始时间: 2020年10月5日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

Clinically appropriate thresholds were set for the number of achieved goals regarding the 6 treatment goals of Gaucher disease, and summary statistics of Lyso-Gb1 concentrations were calculated to compare the factors by group of threshold. In 14 subjects with 100% achievement as the threshold and 6 subjects with other values, t-test yielded p=0.117 and Wilcoxon rank sum test yielded p=0.0588 for the between-group comparison.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 1. In the opinion of the investigator, the participant is capable of understanding and complying with protocol requirements.
  • 2. The participant or, when applicable, the participant's legally acceptable representative signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.
  • 3. Participants who are diagnosed as Gaucher disease.
  • 4. Patients who have been treated with velaglucerase alfa for at least 3 months.

排除标准

  • Any reason that, in the Investigator's opinion, makes the patient unsuitable to participate in this study.

研究者

发起方
Contact for Clinical Trial Information

相似试验